REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $11,000 | +266.7% | 21,500 | 0.0% | 0.00% | +200.0% |
| Q4 2016 | $3,000 | -40.0% | 21,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $5,000 | 0.0% | 21,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | -28.6% | 21,500 | 0.0% | 0.00% | -66.7% |
| Q1 2016 | $7,000 | -12.5% | 21,500 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $8,000 | -27.3% | 21,500 | 0.0% | 0.00% | -40.0% |
| Q3 2015 | $11,000 | -8.3% | 21,500 | +7.5% | 0.01% | +66.7% |
| Q2 2015 | $12,000 | -20.0% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $15,000 | -28.6% | 20,000 | -33.3% | 0.01% | -33.3% |
| Q4 2014 | $21,000 | +162.5% | 30,000 | +200.0% | 0.01% | +125.0% |
| Q3 2014 | $8,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|